These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8628497)

  • 1. Elevated serum levels of manganese superoxide dismutase in polymyositis and dermatomyositis.
    Mokuno K; Kiyosawa K; Honda H; Hirose Y; Murayama T; Yoneyama S; Kato K
    Neurology; 1996 May; 46(5):1445-7. PubMed ID: 8628497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
    Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
    Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis.
    Samsonov MY; Nassonov EL; Tilz GP; Geht BM; Demel U; Gurkina GT; Shtutman VZ; Guseva AG; Wachter H; Fuchs D
    Br J Rheumatol; 1997 Jun; 36(6):656-60. PubMed ID: 9236675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
    Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
    Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
    Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
    Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
    Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
    Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis.
    Kubo M; Ihn H; Yamane K; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    Br J Dermatol; 2000 Aug; 143(2):392-8. PubMed ID: 10951151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F; Shu XM; Wang DX; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases.
    Shen H; Xia L; Lu J
    Cytokine; 2012 Nov; 60(2):334-7. PubMed ID: 22863719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
    Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
    Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.
    Jiang Q; Li Y; Xia L; Shen H; Lu J
    J Interferon Cytokine Res; 2019 Nov; 39(11):720-725. PubMed ID: 31274382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum manganese-superoxide dismutase in patients with neuromuscular disorders as judged by an ELISA.
    Yahara O; Hashimoto K; Taniguchi N; Ishikawa M; Sato Y; Yamashita H; Ohno H
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):315-26. PubMed ID: 1947435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum KL-6 in adult patients with polymyositis and dermatomyositis.
    Kubo M; Ihn H; Yamane K; Kikuchi K; Yazawa N; Soma Y; Tamaki K
    Rheumatology (Oxford); 2000 Jun; 39(6):632-6. PubMed ID: 10888708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of vascular endothelial growth factor in collagen diseases.
    Kikuchi K; Kubo M; Kadono T; Yazawa N; IHN H; Tamaki K
    Br J Dermatol; 1998 Dec; 139(6):1049-51. PubMed ID: 9990370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.
    Yuan L; Yao L; Zhao L; Xia L; Shen H; Lu J
    Clin Exp Rheumatol; 2013; 31(3):428-32. PubMed ID: 23485578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The levels and clinical significance of serum B cell activating factor in Chinese patients with polymyositis or dermatomyositis].
    Peng QL; Xie Y; Zhang RF; Shu XM; Wang GC
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):210-3. PubMed ID: 22781895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity.
    Suzuki F; Kubota T; Miyazaki Y; Ishikawa K; Ebisawa M; Hirohata S; Ogura T; Mizusawa H; Imai T; Miyasaka N; Nanki T
    Arthritis Res Ther; 2012 Mar; 14(2):R48. PubMed ID: 22394569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases.
    Scola RH; Werneck LC; Prevedello DM; Toderke EL; Iwamoto FM
    Arq Neuropsiquiatr; 2000 Sep; 58(3B):789-99. PubMed ID: 11018813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant status of serum bilirubin and uric acid in patients with polymyositis and dermatomyositis.
    Chen Z; Su Z; Pang W; Huang Y; Lin J; Ding Z; Wu S; Xu S; Quan W; Zheng J; Chen H; Li Z; Li X; Li J; Weng Y; Zhang X
    Int J Neurosci; 2017 Jul; 127(7):617-623. PubMed ID: 27485272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.